{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-000232","form_type":"8-K/A","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2023-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.130837+00:00","generated_at":"2026-06-20T19:33:03.099257+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Arcadia Biosciences discloses CFO Thomas Schaefer compensation: $260K base, 40% bonus target, 50,000 stock options","bullets":["Base salary $260,000 per annum; target bonus 40% of base salary as per employment letter effective Jan 3, 2023.","Granted stock options to purchase 50,000 shares vesting over 4 years with 1-year cliff under 2015 Omnibus Plan.","Severance: 6-month base salary non-CIC; 12-month salary + 100% equity vesting if terminated within 12 months post-change-in-control.","Employment is at-will; CIC agreement expires on third anniversary of effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-000232","json":"https://secwatch.observer/filing/0000950170-23-000232.json","markdown":"https://secwatch.observer/filing/0000950170-23-000232.md","text":"https://secwatch.observer/filing/0000950170-23-000232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023000232/0000950170-23-000232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017023000232/rkda-20230103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T19:33:03.099257+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}